nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A closer inspection of tedizolid
|
Drekonja, Dimitri Maximilian |
|
2015 |
15 |
4 |
p. 374- 1 p. |
artikel |
2 |
A closer inspection of tedizolid
|
Taylor, James |
|
2015 |
15 |
4 |
p. 374- 1 p. |
artikel |
3 |
A closer inspection of tedizolid – Authors' reply
|
Prokocimer, Philippe |
|
2015 |
15 |
4 |
p. 375- 1 p. |
artikel |
4 |
Applied public health research on the frontline
|
Palmu, Arto A |
|
2015 |
15 |
4 |
p. 365-366 2 p. |
artikel |
5 |
Assessing a broader user base for new HCV drug
|
Sekkides, Onisillos |
|
2015 |
15 |
4 |
p. 383- 1 p. |
artikel |
6 |
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases
|
Schelenz, Silke |
|
2015 |
15 |
4 |
p. 461-474 14 p. |
artikel |
7 |
Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis
|
Rambaud-Althaus, Clotilde |
|
2015 |
15 |
4 |
p. 439-450 12 p. |
artikel |
8 |
Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial
|
Hamaluba, Mainga |
|
2015 |
15 |
4 |
p. 405-414 10 p. |
artikel |
9 |
Comprehensive approach to better malaria control
|
The Lancet Infectious Diseases, |
|
2015 |
15 |
4 |
p. 361- 1 p. |
artikel |
10 |
Corrections
|
|
|
2015 |
15 |
4 |
p. 373- 1 p. |
artikel |
11 |
Corrections
|
|
|
2015 |
15 |
4 |
p. 373- 1 p. |
artikel |
12 |
Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study
|
Bar-Zeev, Naor |
|
2015 |
15 |
4 |
p. 422-428 7 p. |
artikel |
13 |
Emphysematous osteomyelitis
|
Larsen, Jörg |
|
2015 |
15 |
4 |
p. 486- 1 p. |
artikel |
14 |
Filovirus epidemic in 1956 in Bili, DRC
|
Colebunders, Robert |
|
2015 |
15 |
4 |
p. 379- 1 p. |
artikel |
15 |
Five-drug antiretroviral therapy for primary HIV infection?
|
Debyser, Zeger |
|
2015 |
15 |
4 |
p. 362-363 2 p. |
artikel |
16 |
Highlights from the 22nd CROI
|
Hayward, Peter |
|
2015 |
15 |
4 |
p. 382- 1 p. |
artikel |
17 |
Hope for non-responders with hepatitis C virus and cirrhosis
|
Dusheiko, Geoffrey |
|
2015 |
15 |
4 |
p. 363-365 3 p. |
artikel |
18 |
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
|
Ravimohan, Shruthi |
|
2015 |
15 |
4 |
p. 429-438 10 p. |
artikel |
19 |
Improving diagnosis of childhood pneumonia
|
Qazi, Shamim |
|
2015 |
15 |
4 |
p. 372-373 2 p. |
artikel |
20 |
India tackles lymphatic filariasis
|
Bagcchi, Sanjeet |
|
2015 |
15 |
4 |
p. 380- 1 p. |
artikel |
21 |
Infectious disease surveillance update
|
Zwizwai, Ruth |
|
2015 |
15 |
4 |
p. 383- 1 p. |
artikel |
22 |
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial
|
Chéret, Antoine |
|
2015 |
15 |
4 |
p. 387-396 10 p. |
artikel |
23 |
Investment in antibiotics against pneumonia
|
Fitchett, Joseph R |
|
2015 |
15 |
4 |
p. 376-377 2 p. |
artikel |
24 |
Investment in antibiotics against pneumonia
|
Fernandes, Prabhavathi |
|
2015 |
15 |
4 |
p. 376- 1 p. |
artikel |
25 |
“John”—Searching for you in the darkness
|
Ambrogi, Marco de |
|
2015 |
15 |
4 |
p. 386- 1 p. |
artikel |
26 |
β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?
|
Harris, Patrick N A |
|
2015 |
15 |
4 |
p. 475-485 11 p. |
artikel |
27 |
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
|
Bourlière, Marc |
|
2015 |
15 |
4 |
p. 397-404 8 p. |
artikel |
28 |
Overconsumption of antibiotics
|
Morrill, Haley J |
|
2015 |
15 |
4 |
p. 377-378 2 p. |
artikel |
29 |
Overconsumption of antibiotics
|
Ghafur, Abdul |
|
2015 |
15 |
4 |
p. 377- 1 p. |
artikel |
30 |
Probiotics to prevent early-life infection
|
Strunk, Tobias |
|
2015 |
15 |
4 |
p. 378-379 2 p. |
artikel |
31 |
Research brief
|
Bradbury, Jane |
|
2015 |
15 |
4 |
p. 384- 1 p. |
artikel |
32 |
Resistance to hepatitis C virus: potential genetic and immunological determinants
|
Mina, Michael M |
|
2015 |
15 |
4 |
p. 451-460 10 p. |
artikel |
33 |
Rotavirus vaccines roll-out in resource-deprived regions
|
O'Ryan, Miguel L |
|
2015 |
15 |
4 |
p. 368-370 3 p. |
artikel |
34 |
Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker
|
Tun, Kyaw M |
|
2015 |
15 |
4 |
p. 415-421 7 p. |
artikel |
35 |
TB and Me
|
Burki, Talha |
|
2015 |
15 |
4 |
p. 385- 1 p. |
artikel |
36 |
The health of nations
|
Ranscombe, Peter |
|
2015 |
15 |
4 |
p. 381- 1 p. |
artikel |
37 |
Towards real-time monitoring of artemisinin resistance
|
Menard, Didier |
|
2015 |
15 |
4 |
p. 367-368 2 p. |
artikel |
38 |
Tuberculosis-associated immune reconstitution inflammatory syndrome: a manifestation of adaptive or innate immunity?
|
Goovaerts, Odin |
|
2015 |
15 |
4 |
p. 370-371 2 p. |
artikel |